This study examined serious lung infections, known as pulmonary exacerbations, in people with cystic fibrosis (CF) who needed treatment with intravenous (IV) antibiotics. These severe flare-ups are important because they can cause lasting drops in lung function and...
The BEAT CF team has published a paper in the jornual Respiratory Medicine. The open access article describes the characteristics of the participants who enrolled in the prospective BEAT CF cohort. To read the article, please visit: BEAT-CF (Bayesian Evidence Adaptive...
Researchers from Telethon Kids Institute are conducting a survey to understand what health outcomes are most important to people with CF. Often, researchers decide on outcomes for clinical trials without community input. This 12 question survey will help inform what...
We are excited to announce that the BEAT CF platform has received ethical approval from the Child and Adolescent Health Service Human Research Ethics Committee at Perth Children’s Hospital. The ethical approval was given for the data collection phase of the study and...
The BEAT CF investigator team has published a paper in the Journal Frontiers in Pharmacology. The open access article explains the need for novel trials in cystic fibrosis and provides a foundation for the BEAT CF study. The article also explains benefits of a REMAP...
